The Industry Ministry has said that it is continuing to encourage the development of the specialty chemical industry to ...

Ron Lanton, Partner, Lanton Law, outlines how the MFN executive order may face significant legal challenges from the pharmaceutical industry, citing concerns over due process, intellectual property, ...

In a bold move to reshape the landscape of pharmaceutical manufacturing in the US, President Donald Trump has signed an ...

Biotechnology Innovation Organization trade show is expected to bring about 20,000 participants to Boston starting on Monday.

Recursion Pharmaceuticals said on Tuesday it will lay off around 20% of its workforce and focus on developing drugs for rare diseases and cancers to reduce cash burn during a prolonged biotech ...

AI startup ByteBrain is transforming clinical trials with agent-based optimization, cutting costs, boosting efficiency, and ...

Fears about the FDA mposing steep barriers to gene therapies for rare diseases appeared moot at an agency roundtable ...

MUSC research to use he immune system to fight cancer shows it can be done safer, cheaper and better. An SC company pushing ...

While many often say the pharmaceutical industry has the most powerful lobby, the truth is many politicians have grown ...

GenAI is changing pharma operations. Explore real-world tools and use cases for AI in pharmaceutical industry workflows.

Tariffs, funding cuts threaten the ecosystem of companies and research institutes that have made the Commonwealth a biotech ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...